메티실린 저항성에 따른 황색포도알균 각막염에 대한 임상분석
Clinical Analysis of Staphylococcus aureus Keratitis according to Methicillin-resistance
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: 황색포도알균 각막염에서 메티실린 저항성과 감수성 균주 간의 임상양상과 항생제감수성, 치료성적을 비교해보고자 하였다. 대상과 방법: 1998년부터 2014년까지 황색포도알균 각막염으로 진단받고 2개월 이상 추적 관찰했던 46명 환자의 의무기록을 후향적으로 분석하였다. Methicillin-resistant Staphylococcus aureus (MRSA)와 methicillin-sensitive Staphylococcus aureus (MSSA) 두 군으로 나누어 역학적 특성과 선행요인, 초기 임상양상, 항생제감수성, 치료성적을 비교 분석하였고 로지스틱 회귀분석을 통해 시력호전불량 위험인자를 확인하였다. 결과: 전체 46안 중 MRSA는 15안(33%), MSSA는 31안(67%)이었다. 남자(61%)와 60세 이상(48%)에서 흔했고, 선행요인으로 안구표면질환/안수술력과 외상이 많았다. MRSA 감수성은 vancomycin (100%)에서 높았고, oxacillin (0%)과 gentamicin (13.3%), trimethoprim/ sulfamethoxazole (53.3%)에서 낮았다. Fluoroquinolone은 81.3% (MRSA 64.3%, MSSA 94.4%; p=0.064)의 감수성을 보였다. 초기 임상소견은 두 군 간에 유의한 차이가 없었다. 교정시력 0.5 이상의 비율은 초진 시 24.4%에서 치료 후 44.4%로 유의하게 증가하였다(p=0.046). 시력과 합병증, 수술 여부를 종합한 치료성적은 두 군 간에 유의한 차이가 없었다. 시력호전불량 위험인자는 전체 군에서 초진 교정시력 0.1 미만(p=0.033)이 확인되었다. 결론: 황색포도알균 각막염 중 MRSA는 33%를 차지하였다. 치료 후 교정시력 0.5 이상의 비율은 전체 안에서 증가하였다. 두 군 간에 항생제감수성을 제외한 역학적 특성과 선행요인, 초기 임상양상, 치료성적 등은 유의한 차이가 없었다. 메티실린 저항성뿐만 아니라 임상 경과에 영향을 미치는 여러 요소를 종합적으로 고려한 치료 접근이 바람직할 것으로 생각된다.
Abstract
Purpose: This study analyzed clinical characteristics of Staphylococcus aureus keratitis according to methicillin-resistance. Methods: The authors performed a retrospective chart review of 46 isolates in 46 eyes with Staphylococcus aureus keratitis that were followed up for more than 2 months between January 1998 and December 2014. Comparative analyses of the epidemiology, predisposing factors, initial clinical manifestations, antibiotics susceptibility and clinical outcome between methicillin-resistant Staphylococcus aureus (MRSA) keratitis and methicillin-sensitive Staphylococcus aureus (MSSA) keratitis were performed. Risk factors of poor visual outcome were analyzed using logistic regression analysis. Results: Among 46 eyes, MRSA was present in 15 eyes (33%) and MSSA in 31 eyes (67%). Male (61%) and older than 60 year-old group (48%) were common. Ocular surface disease/ocular surgery history and trauma were more common as a predisposing factor. Vancomycin was 100% sensitive to both the MRSA and MSSA groups. Antibiotics susceptibility to MRSA was significantly low in the oxacillin (0%), gentamicin (13.3%) and trimethoprim/sulfamethoxazole (53.3%) groups. Sensitivity to fluoroquinolone was 81.3% (MRSA 64.3% vs. MSSA 94.4%; p = 0.064). There were no differences in early corneal findings between the groups. The ratio of BCVA 0.5 or more was 24.4% initially and increased to 44.4% after treatment among all eyes (p = 0.046). Risk factors for poor visual outcomes included a BCVA less than 0.1 at initial evaluation (p = 0.033). Conclusions: Among eyes with Staphylococcus aureus keratitis, 33% were MRSA. The ratio of BCVA 0.5 or more increased after treatment among all eyes. There were no differences between MRSA and MSSA eyes in terms of epidemiology, predisposing factors, initial clinical manifestations or clinical outcome, except for antibiotic susceptibility. For positive patient outcomes, a treatment approach considering methicillin-resistance as well as various factors affecting clinical course is recommended.
참고문헌 (39)
- Hawser SP, "Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009", Int J Antimicrob Agents, 37, pp.219~224 (2011)
- DeLeo FR, "Community-associated meticillin-resistant Staphylococcus aureus", Lancet, 375, pp.1557~1568 (2010)
- Chang VS, "Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-Year Review", Cornea, 34, pp.698~703 (2015)
- Sotozono C, "Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea", Cornea, 21(7 Suppl), pp.S94~S101 (2002)
- Hsiao CH, "Methicillin-resistant Staphylococcus aureus ocular infection: a 10-year hospital-based study", Ophthalmology, 119, pp.522~527 (2012)
- Freidlin J, "Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus", Am J Ophthalmol, 144, pp.313~315 (2007)
- Mukerji N, "Technique of area measurement of epithelial defects", Cornea, 22, pp.549~551 (2003)
- 임수호, "입원치료를 시행한 세균각막염에 대한 12년간의 분석: 원인균주와 항생제내성", 대한안과학회지, 53(3), pp.372~384 (2012), 대한안과학회
- Jorgensen JH, "New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria", Clin Infect Dis, 44, pp.280~286 (2007)
- 신소연, "Evaluation of the Vitek 2 Korean Antimicrobial Susceptibility Testing Cards AST N056 and AST N055", Annals of Clinical Microbiology, 11(1), pp.23~28 (2008), 대한임상미생물학회
- Green MD, "Apel AJ", Clin Exp Ophthalmol, 35, pp.421~426 (2007)
- Deurenberg RH, "The evolution of Staphylococcus aureus", Infect Genet Evol, 8, pp.747~763 (2008)
- Tacconelli E, "Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis", J Antimicrob Chemother, 61, pp.26~38 (2008)
- Bartoloni A, "Methicillin-resistant Staphylococcus aureus in hospitalized patients from the Bolivian Chaco", Int J Infect Dis, 30, pp.156~160 (2015)
- Cosgrove SE, "Comparison of mortality associated with methicillin-resistant and methicillinsusceptible Staphylococcus aureus bacteremia: a meta-analysis", Clin Infect Dis, 36, pp.53~59 (2003)
- Melzer M, "Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia", Clin Infect Dis, 37, pp.1453~1460 (2003)
- Blot SI, "Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus", Arch Intern Med, 162, pp.2229~2235 (2002)
- Zetola N, "Communityacquired meticillin-resistant Staphylococcus aureus: an emerging threat", Lancet Infect Dis, 5, pp.275~286 (2005)
- Mohammadi S, "Emergence of SCCmec type Ⅲ with variable antimicrobial resistance profiles and spa types among methicillin-resistant Staphylococcus aureus isolated from healthcare- and community-acquired infections in the west of Iran", Int J Infect Dis, 25, pp.152~158 (2014)
- Ong SJ, "Staphylococcus aureus keratitis:a review of hospital cases", PLoS One, 8, pp.e80119~ (2013)
- 김미래, "그람양성세균각막염에 대한 임상적, 미생물학적 분석: 15년 연구", 대한안과학회지, 55(10), pp.1432~1444 (2014), 대한안과학회
- Chuang CC, "Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities", PLoS One, 8, pp.e42437~ (2012)
- 조은영, "15년간 그람음성세균각막염의 임상적 고찰", 대한안과학회지, 56(10), pp.1479~1488 (2015), 대한안과학회
- Hori Y, "Fluoroquinolone-resistant bacteria and methicillin-resistant Staphylococci from normal preoperative conjunctiva", J Cataract Refract Surg, 34, pp.711~712 (2008)
- Fukuda M, "Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops", Cornea, 21(7 Suppl), pp.S86~S89 (2002)
- Kato T, "Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients", Jpn J Ophthalmol, 42, pp.461~465 (1998)
- Otri AM, "Profile of sight-threatening infectious keratitis: a prospective study", Acta Ophthalmol, 91, pp.643~651 (2013)
- Shanmuganathan VA, "External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA)", Eye (Lond), 19, pp.284~291 (2005)
- Harbarth S, "Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus", Arch Intern Med, 158, pp.182~189 (1998)
- Vola ME, "Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections", Arq Bras Oftalmol, 76, pp.350~353 (2013)
- Marangon FB, "Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis", Am J Ophthalmol, 137, pp.453~458 (2004)
- Huz JI, "Clinical outcomes and antibiotic susceptibilities of Staphylococcus aureus endophthalmitis", Graefes Arch Clin Exp Ophthalmol, 255, pp.651~656 (2017)
- Asbell PA, "Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005", J Cataract Refract Surg, 34, pp.814~818 (2008)
- Alexandrakis G, "Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones", Ophthalmology, 107, pp.1497~1502 (2000)
- Saleh M, "Ocular penetration of topically applied linezolid in a rabbit model", J Cataract Refract Surg, 36, pp.488~492 (2010)
- Miedziak AI, "Risk factors in microbial keratitis leading to penetrating keratoplasty", Ophthalmology, 106, pp.1166~1170 (1999)
- Major JC Jr, "Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes", Am J Ophthalmol, 149, pp.278~283 (2010)
- Gordon RJ, "Pathogenesis of methicillin-resistant Staphylococcus aureus infection", Clin Infect Dis, 46(Suppl 5), pp.S350~S359 (2008)
- Rozgonyi F, "Is MRSA more virulent than MSSA?", Clin Microbiol Infect, 13, pp.843~845 (2007)
